Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: ICON PLC

Market Cap 10.97B 9.46B 8.7B 8.19B 15.39B 1,035B 15.52B 103B 40.14B 508B 41.17B 40.29B 1,758B P/E 2026 *
22.8x
P/E 2027 * 18.4x
Enterprise Value 13.26B 11.44B 10.52B 9.9B 18.6B 1,252B 18.76B 125B 48.53B 614B 49.77B 48.71B 2,125B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.53x
Free-Float
99.56%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 48 2025-09-30
Director of Finance/CFO 53 2024-09-30
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 73 2002-10-31
Chairman 63 2017-02-28
Director/Board Member 67 2017-10-03
Change 5-day change 1-year change 3-year change Capi.($)
+526.18%-8.66% - - 10.97B
-0.85%-0.65%-12.65%-10.97% 43.44B
+0.76%+9.42%+303.09%+540.82% 33.54B
-4.74%-6.31%+10.75%-20.99% 28.48B
-0.47%-0.35%+3.38%+31.20% 29.2B
+0.06%+4.36%+13.31%+21.11% 25.34B
-0.02%+10.18% - - 14.36B
-0.98%-1.86%+53.43%+106.06% 13.05B
-1.12%-3.89%+2.21%+3.07% 12.67B
+1.67%+1.35%+105.56%+81.16% 12.28B
Average -0.62%+1.33%+59.89%+93.93% 23.6B
Weighted average by Cap. -0.77%+1.35%+62.52%+105.71%

Financials

2026 *2027 *
Net sales 8.02B 6.92B 6.36B 5.99B 11.25B 757B 11.34B 75.38B 29.35B 371B 30.1B 29.46B 1,285B 8.22B 7.09B 6.52B 6.14B 11.53B 776B 11.63B 77.24B 30.07B 381B 30.84B 30.18B 1,317B
Net income 508M 439M 403M 380M 713M 47.98B 719M 4.78B 1.86B 23.55B 1.91B 1.87B 81.46B 603M 520M 478M 450M 845M 56.86B 852M 5.66B 2.2B 27.91B 2.26B 2.21B 96.55B
Net Debt 2.29B 1.98B 1.82B 1.71B 3.21B 216B 3.24B 21.54B 8.39B 106B 8.6B 8.42B 367B 1.63B 1.41B 1.29B 1.22B 2.29B 154B 2.31B 15.32B 5.97B 75.5B 6.12B 5.99B 261B
Logo ICON PLC
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!